ScoreWhy is Novavax, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -32.72
2
The company has declared negative results for the last 4 consecutive quarters
- The company has declared negative results in Sep 25 after 2 consecutive negative quarters
- PRE-TAX PROFIT(Q) At USD -47.58 MM has Fallen at -428.7%
- NET PROFIT(Q) At USD -49.29 MM has Fallen at -451.66%
- INTEREST(Q) At USD 5.69 MM has Grown at 16.08%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 21.68%, its profits have risen by 439.8% ; the PEG ratio of the company is 0
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Novavax, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Novavax, Inc.
21.68%
-0.52
65.43%
S&P 500
15.76%
1.20
13.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.76%
EBIT Growth (5y)
27.43%
EBIT to Interest (avg)
-32.72
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
7.49
Sales to Capital Employed (avg)
2.45
Tax Ratio
2.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
82.78%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
-10.81
EV to EBIT
1.58
EV to EBITDA
1.51
EV to Capital Employed
-1.45
EV to Sales
0.79
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-29What is not working for the Company
PRE-TAX PROFIT(Q)
At USD -47.58 MM has Fallen at -428.7%
NET PROFIT(Q)
At USD -49.29 MM has Fallen at -451.66%
INTEREST(Q)
At USD 5.69 MM has Grown at 16.08%
RAW MATERIAL COST(Y)
Grown by 17.57% (YoY
NET SALES(Q)
Lowest at USD 56.7 MM
Here's what is not working for Novavax, Inc.
Net Sales
At USD 56.7 MM has Fallen at -61.97%
over average net sales of the previous four periods of USD 149.08 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -47.58 MM has Fallen at -428.7%
over average net sales of the previous four periods of USD 14.47 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -49.29 MM has Fallen at -451.66%
over average net sales of the previous four periods of USD 14.02 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
At USD 5.69 MM has Grown at 16.08%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Net Sales
Lowest at USD 56.7 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Raw Material Cost
Grown by 17.57% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
